Breaking News & Top Stories3 stories from 3 sources
Kenya has officially launched the nationwide rollout of Lenacapavir (LEN), a new long-acting injectable drug for HIV prevention, on Thursday, February 27, 2026. This significant advancement offers a more convenient option alongside existing oral and injectable PrEP methods. Kenya is also seeking to enhance its digital health infrastructure and reduce maternal deaths by partnering with the World Bank, a key focus for President William Ruto's administration. Separately, AMPATH Kenya has launched a new national breast cancer care initiative aimed at improving access to high-quality treatment and reducing the disease's burden across the country.
Kenya has officially launched the nationwide rollout of Lenacapavir (LEN), a new long-acting injectable drug for HIV prevention, on Thursday, February 27, 2026. This significant advancement offers a more convenient option alongside existing oral and injectable PrEP methods.
Summary & Analysis
AMPATH Kenya has launched a new national breast cancer care initiative aimed at improving access to high-quality treatment and reducing the disease's burden across the country.
Summary & Analysis
Kenya is seeking to enhance its digital health infrastructure and reduce maternal deaths by partnering with the World Bank. This initiative is a key focus for President William Ruto's administration.
Summary & Analysis
